October 2015
Overweight
Bristol-Myers Squibb Company BMY. SPAY US
Price: S59.20
Opdivo/ Yervoy approval an incremental positive -
30 September 2015
ALERT
This morning, the FDA announced that ... approved Bristol's Opdivo Pharmaceuticals — Major &
(PD-1) in combination with Yervoy (CTLA4) for previously untreated Specialty
BRAF wild-type melanoma patients. This approval follows the Chris Schott ... which was the basis of this filing. Overall,
Bloomberg .1.'`.1A SCHOTT <GO,
Opdivo/ Yervoy is the first I/O combo to be approved and given the
risk/benefit profile